The impact of Host vs. Graft mismatches on rejection of haploidentical bone marrow transplants in thalassemia patients using posttransplant cyclophosphamide

Bone Marrow Transplant. 2020 Sep;55(9):1824-1828. doi: 10.1038/s41409-019-0692-0. Epub 2019 Sep 30.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Marrow Transplantation
  • Cyclophosphamide
  • Graft Rejection
  • Graft vs Host Disease*
  • Humans
  • Thalassemia* / therapy
  • Transplantation, Haploidentical

Substances

  • Cyclophosphamide